The Oral Health Foundation launches national mouth cancer campaign
More than 130 people joined The Oral Health Foundation yesterday, at the Houses of Parliament, as the charity announced this year's Mouth Cancer Action Month.
78 NHS trusts to receive new cancer screening machines
The 78 trusts, that have now been announced, will receive funding for new machines that will improve patient experience and lead to earlier cancer diagnosis.
New test could diagnose ovarian cancer up to two years earlier
A new test developed at Queen's University could allow ovarian cancer to be diagnosed at a stage up to two years earlier than current methods.
NHS to prioritise early cancer detection and survival
Cancer diagnosis will be made faster and more accurate with new technology to improve detection and survival, Matt Hancock announces.
Men’s Health Week: Raising awareness about male breast cancer
During Men’s Health Week (10-16 June 2019) Breast Cancer Haven aims to raise awareness of breast cancer amongst the male population and remind the public that the charity’s services are available to anyone affected by the disease.
The emotional impact of false positive cancer diagnosis
False positives in cancer diagnosis cost NHS millions each year and cause huge anxiety across the nation, Wesley Baker, CEO of ANCON Medical discusses the impact of outdated cancer diagnosis.
Urine test could replace smear test for cervical cancer
University of Manchester scientists latest research finds that urine testing may be as good as the smear test for preventing cervical cancer.
Towards Precision Oncology in Breast Cancer
Predicting Response to Neoadjuvant Chemotherapy Using Tumor Vasculature Characteristics.
Why you should accept your smear test invitation
Everyone susceptible to cervical cancer should understand how to prevent it. Cervical screening saves 2,000 lives each year, read on to find out how to potentially save your own.
Prostate cancer: A riddle wrapped in a mystery inside an enigma
Professor Malcolm Mason, Cancer Research UK’s Prostate Cancer Expert reveals why prostate cancer is a riddle wrapped in a mystery inside an enigma
Bowel cancer screening should start at age 50, according to expert committee
The independent expert screening committee has recommended that bowel cancer screening in England should in future start at age 50 to prevent late diagnosis
Prostate Cancer UK calls for screening programme and more research
Angela Culhane, Prostate Cancer UK Chief Executive discusses the tools needed to create a screening programme to stop prostate cancer killing men.
We need to think differently about cancer to save more lives
Sir Harpal Kumar, former CEO of Cancer Research UK, outlines his vision for cancer in the future and said that earlier diagnosis would enable the UK to catch up with its international counterparts in terms of survival rates and would also make the NHS more efficient
Living with acute myeloid leukaemia (AML)
Bethany Torr, Campaigns and Advocacy Officer at Leukaemia Care explores the challenges of living with acute myeloid leukaemia (AML)
Prostate cancer: A wake-up call for men
Roger Wotton, Chairman of Tackle Prostate Cancer explores the key issues around prostate cancer, the most common cancer in men.
TGF-β signalling – Tumor biology in prostate cancer
Identifying the molecular signalling pathways leading to advanced prostate cancer to improve therapy and diagnosis
New data reveals cancer diagnosis could affect treatment options
Data from Public Health England shows that cancer diagnosis could impact upon which kind of treatment a patient receives.
Prostate cancer: Enigmatic, with different shades
Professor Ghulam Nabi from the University of Dundee explores the subject of the enigmatic prostate cancer, with different shades
Artificial Intelligence to improve cancer diagnosis
Ambitious new plans set out by the Prime Minister today will see around 22,000 fewer people dying from cancer each year by 2033
Prostate cancer treatment receives £75m funding boost
Prime Minister Theresa May has announced a further £75m in funding for “earlier and faster” diagnosis and treatment of prostate cancer, which kills more than 10,000 men each year
